22
Participants
Start Date
May 31, 2012
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
TRC105
10 mg/kg weekly by intravenous administration on Days 1, 8, 15 and 22 of each 28-day cycle
Bevacizumab
IV
Ohio State University, Columbus
University Hospitals of Cleveland, Cleveland
Cleveland Clinic, Cleveland
University of Cincinnati, Cincinnati
The Cleveland Clinic
OTHER
Case Comprehensive Cancer Center
OTHER
Tracon Pharmaceuticals Inc.
INDUSTRY